{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-000422","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2023-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.265681+00:00","generated_at":"2026-06-20T21:04:25.896227+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Journey Medical enters ATM sales agreement with B. Riley for up to 4.9M shares","bullets":["Company may offer and sell up to 4,900,000 shares of common stock through Agent B. Riley Securities in at-the-market offerings.","Sales require effectiveness of new S-3 registration statement filed December 30, 2022; Agent commission is 3.0% of gross proceeds.","Company is not obligated to sell any shares; agreement continues until all shares sold or terminated by either party.","Customary indemnification and expense reimbursement provided to Agent; offering may be conducted with price, time, or size limits."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-000422","json":"https://secwatch.observer/filing/0001104659-23-000422.json","markdown":"https://secwatch.observer/filing/0001104659-23-000422.md","text":"https://secwatch.observer/filing/0001104659-23-000422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/0001104659-23-000422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/tm231431d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:04:25.896227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b8b93be4aca95b9b1838319c84d427d36635fd11","claim":"Journey Medical Corp entered into At Market Issuance Sales Agreement with B. Riley Securities, Inc. valued at Agreement for the issuance and sale of up to 4,900,000 shares of common stock through agent at marke (effective 2022-12-30).","evidence_excerpt":"On December 30, 2022, Journey Medical Corporation (the “Company”) entered into an At Market Issuance Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”), under which the Company may offer and sell, from time to time at its sole discretion, 4,900,000 shares of its common stock, par value $0.0001 per share (the “Shares”), through or to the Agent.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465923000422/0001104659-23-000422-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"B. Riley Securities, Inc."},{"label":"Value","value":"Agreement for the issuance and sale of up to 4,900,000 shares of common stock through agent at marke"},{"label":"Effective","value":"2022-12-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}